General Information

  • "Hydroxysomes™" -- New dermal delivery system for the development of new pharmaceutical drugs and/or innovative skin care products
  • Develop new formulations for patent life extension
  • Improve pharmacokinetics and pharmacodynamics
  • Deliver to Stratum corneum
  • No disruption to the integrity of Sc
  • High binding capacity
  • Ability to bind and deliver a broad range of hydrophilic and lipophilic bio-actives such as proteins, peptides, steroids, antibiotics, lipids, vitamins, anti-oxidants, carbohydrates, and nucleic acids

Licensing Technology

  • To inquire about licensing Hydroxysomes™ technology, please complete this form and email it to info@lsc-inc.com or fax it to +1 650-373-0455.